Skip to Main Content

Paper Details

Visual Field Endpoints for Neuroprotective Trials: A Case for AI-Driven Patient Enrichment.
Am J Ophthalmol
4
2022
MD, Patient, patients
Artificial Intelligence, Disease Progression, Follow-Up Studies, Glaucoma, Humans, Intraocular Pressure, Retrospective Studies, Vision Disorders, Visual Field Tests, Visual Fields
Author NameAffiliation
Andrew ChenUniversity of Washington
Giovanni MontesanoUniversity of London, D.P.C) NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology
Randy LuUniversity of Washington
Cecilia S LeeUniversity of Washington
David P CrabbUniversity of London
Aaron LeeUniversity of Washington
  • 1 - 6

Datasets

Release 1.2